Grace Therapeutics, Inc. (GRCE) stock
GRCENasdaqPharmaceutical PreparationsFiscal year ends March 31
$1.73+0.01 (+0.58%)
Close on Nov 18, 2026Market cap $36.39MP/E –Yield –
Grace Therapeutics free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Quarterly free cash flow
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | -$4.21M | – |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | -$23.26M | – |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | -$6.84M | – |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | -$25.32M | – |
See a number that looks wrong?